Anticancer Agents : Design, Synthesis and Evaluation |
Autore | Chen Qiao-Hong |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (606 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
benzofurans
chemical synthesis cytotoxic properties HeLa MOLT-4 K562 anticancer anti-neuroinflammation coumarin dihydroartemisinin flavonoids allene E-stereoselective regioselective anti-cancer activity cyanopyridone substituted pyridine pyridotriazine pyrazolopyridine thioxotriazopyridine anticancer activity HepG2 antitumor activity computational docking MDM2-p53 interaction xanthones yeast-based assays estrone derivatives hydrazine N-substituted pyrazoline anti-ovarian cancer topoisomerase II inhibitor kinase inhibitor antiproliferative agent urea synthesis antiproliferative activity apoptosis indoleamine 2,3-dioxygenase inhibitor anti-tumor immune modulation tryptophan metabolism taxoids βIII-tubulin P-glycoprotein drug resistance thiopene thienopyrimidinone thiazolidinone breast cancer benzofuran–pyrazole nanoparticles cytotoxic activity PARP-1 inhibition 3,6-dibromocarbazole 5-bromoindole carbazole actin migration Thienopyrimidine Pyrazole PI3Kα inhibitor quinazolin-4(3H)-one quinazolin-4(3H)-thione Schiff base antioxidant activity DFT study ortho-quinones beta-lapachone tanshione IIA PI3Ks PI3Kδ inhibitors 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide anticancer agents protein–protein interactions virtual screening mimetics drug discovery bivalency polyvalency antitumor cell cycle ovarian cancer P-MAPA IL-12 TLR signaling inflammation chemoresistance 4-(pyridin-4-yloxy)benzamide 1,2,3-triazole c-Met natural product anticancer agent zampanolide Talazoparib PARP inhibitor prodrug o-nitro-benzyl photoactivatable protecting groups salinomycin overcoming drug resistance tumor specificity synergy 5-fluorouracil gemcitabine amides/esters colchicine analogs thiocolchicine colchiceine antimitotic agents hydrates dihydropyranoindole HDAC inhibitors neuroblastoma aromatase MCF-7 NIH3T3 benzimidazole triazolothiadiazine docking ADME organosilicon compounds SILA-409 (Alis-409) SILA-421 (Alis-421) multidrug resistance (MDR) reversal ABCB1 (P-glycoprotein) colon cancer colchicine amide colchicine sulfonamide tubulin inhibitors docking studies crystal structure PROTACs protein degradation IGF-1R Src protein kinase phenylpyrazolopyrimidine enzyme inhibition molecular simulation androgen receptor prostate cancer enzalutamide apalutamide darolutamide triple-negative breast cancer cytotoxicity chrysin analogues flavonoid anticancer compounds |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Anticancer Agents |
Record Nr. | UNINA-9910557129103321 |
Chen Qiao-Hong | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Natural Product from the Deep Sea |
Autore | Umezawa Kazuo |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (116 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
deep sea marine-derived fungus
Myrothecium sp myrothecol nitric oxide (NO) antioxidant activity macrolactam Deep-Sea-Derived Streptomyces abiotic formation natural product antifungal activity Thorectandra choanoides tryptophan alkaloid indoleamine 2,3-dioxygenase aplysinopsins GNPS molecular network cellular signal transduction bioactive metabolite deep-sea organisms anti-inflammatory agent anticancer agent Mariana Trench Micromonospora provocatoris MT25 desferrioxamine n-acetylglutaminyl glutamine amide 1H-15N 2D-NMR genomics biosynthetic gene clusters stress genes crustins antibacterial peptides hydrothermal vent anti-Gram-negative bacteria Al-crus 3 and Al-crus 7 Trichoderma harziane diterpenes NO inhibition thioester-containing benzoate deep-sea-derived fungus α-glucosidase inhibitory activity docking study |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910566476303321 |
Umezawa Kazuo | ||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Outcomes and Therapeutic Management of Bladder Cancer |
Autore | Moschini Marco |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (120 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
bladder cancer
robotic-assisted open radical cystectomy survival propensity score age urothelial carcinoma outcome anesthesia recovery periods cognitive impairment gamma-cyclodextrins neuromuscular blockade robotic radical cystectomy glycogen clear-cell adenocarcinoma urinary bladder SEER program database female intracorporeal neobladder outcomes robotic sex-sparing methylation biomarkers FOXA1 GATA3 KRT20 molecular markers mRNA muscle-invasive bladder cancer PCR human epidermal growth factor receptor 2 indoleamine 2,3-dioxygenase programmed death ligand-1 immunotherapy nodal disease pN1 neoadjuvant adjuvant chemotherapy |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557114503321 |
Moschini Marco | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|